Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications.
about
Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literatureCost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women.Hypogonadotropic hypogonadism revisited.Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol.
P2860
Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant human follicular s ...... ics and clinical applications.
@en
Recombinant human follicular s ...... ics and clinical applications.
@nl
type
label
Recombinant human follicular s ...... ics and clinical applications.
@en
Recombinant human follicular s ...... ics and clinical applications.
@nl
prefLabel
Recombinant human follicular s ...... ics and clinical applications.
@en
Recombinant human follicular s ...... ics and clinical applications.
@nl
P2860
P1476
Recombinant human follicular s ...... ics and clinical applications.
@en
P2093
Ernesto Bosch
P2860
P304
P356
10.1517/14712598.2010.485607
P407
P577
2010-06-01T00:00:00Z